Boston Scientific has announced that it will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec Scientific, a Chinese medical technology company that offers solutions designed for a variety of interventional procedures. The proposed price is HK$20 per share, which represents a total upfront cash […]
The post Boston Scientific announces investment to acquire majority stake of Acotec Scientific appeared first on Vascular News.
Today, Boston Scientific announced an agreement to acquire Devoro Medical, developer of the Wolf thrombectomy platform. The non-console and lytic-free Wolf technology targets and captures blood clots using finger-like prongs that retrieve and remove thrombi in the arterial and venous systems. “The addition of the Wolf platform advances our efforts to ensure physicians have the […]
The post Boston Scientific announces agreement to acquire Devoro Medical appeared first on Vascular News.